Bactericidal Activity of Rifampin-Amikacin against Mycobacterium ulcerans in Mice

To identify the most active curative treatment of Buruli ulcer, two regimens incorporating the use of rifampin (RIF) were compared with the use of RIF alone in a mouse footpad model of Mycobacterium ulcerans infection. Treatments began after footpad swelling from infection and continued for 12 weeks...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Dega, Herve, Bentoucha, Abdelhalim, Robert, Jerome, Jarlier, Vincent, Grosset, Jacques
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC128793/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12234844/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.10.3193-3196.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!